StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $1,001 at BMO Capital
April 30, 2024 4:50 PM
BMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $1,001.00 (from $900.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Eli Lilly (LLY) PT Raised to $885 at Cantor Fitzgerald
April 30, 2024 2:01 PM
Form 10-Q ELI LILLY & Co For: Mar 31
April 30, 2024 12:05 PM
Midday movers: Eli Lilly, 3M, PayPal rise; Coca-Cola, Tesla fall
April 30, 2024 8:08 AM
Form 8-K ELI LILLY & Co For: Apr 30
April 30, 2024 7:04 AM
Eli Lilly (LLY) stock climbs on gross margin beat, raised 2024 revenue outlook
April 30, 2024 6:59 AM
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
April 30, 2024 6:50 AM
Eli Lilly & Co. (LLY) Tops Q1 EPS by 10c; Raises guidance
April 30, 2024 6:48 AM
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
April 30, 2024 6:45 AM
US stock futures flat as tech rally cools, Fed meeting looms
April 30, 2024 5:19 AM
Eli Lilly & Co. (LLY) May weekly 737 straddle into quarter results
April 30, 2024 3:47 AM
Eli Lilly & Co. (LLY) May weekly option implied volatility into quarter results
April 29, 2024 11:11 AM
